Ditchcarbon
  • Contact
  1. Organizations
  2. Galderma Group AG
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 16 days ago

Galderma Group AG

Company website

Galderma Group AG, a leading global dermatology company, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1981, Galderma has established itself as a pioneer in the dermatological field, focusing on innovative solutions for skin health. The company is renowned for its core products, including aesthetic injectables, prescription dermatology treatments, and skincare solutions, which are distinguished by their scientific rigor and commitment to safety. Galderma's flagship brands, such as Restylane and Differin, have garnered significant market recognition, positioning the company as a trusted name in both medical and aesthetic dermatology. With a strong emphasis on research and development, Galderma continues to achieve notable milestones, solidifying its status as a key player in the global dermatology market.

DitchCarbon Score

How does Galderma Group AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

34

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Galderma Group AG's score of 34 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Galderma Group AG's reported carbon emissions

In 2023, Galderma Group AG reported total carbon emissions of approximately 332,100,000 kg CO2e, with emissions distributed across various scopes: 7,600,000 kg CO2e from Scope 1, 5,500,000 kg CO2e from Scope 2, and the majority, 332,100,000 kg CO2e, from Scope 3. The combined total for Scope 1 and Scope 2 emissions was about 6,800,000 kg CO2e. In 2022, the company reported a total of approximately 7,400,000 kg CO2e for Scope 1 and Scope 2 emissions, with Scope 2 emissions alone at about 5,600,000 kg CO2e. Currently, Galderma has not set specific reduction targets or initiatives, nor do they participate in the Science Based Targets initiative (SBTi). Their emissions data is not cascaded from any parent company, indicating that the figures are solely from Galderma Group AG. Overall, while Galderma has made significant disclosures regarding their emissions, they have yet to establish formal climate commitments or reduction targets.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
-
0,000,000
Scope 2
5,600,000
0,000,000
Scope 3
-
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Galderma Group AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Galderma Group AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Galderma Group AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Revance Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Hugel, Inc.

KR
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Ipsen

FR
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Evolus, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy